Business Practice
CME/CE
Subscribe
BIOSIMILAR APPROVALS
Association of Community Cancer Centers
Prior Authorization Panel Yields Insights Into Role of PBMs in Biosimilar Uptake
March 9th 2022At a session at the Association of Community Cancer Centers’ 2022 Annual Meeting & Cancer Center Business Summit, panelists suggested that the quest for rebates by pharmacy benefit managers (PBMs) prevents uptake on some biosimilars—and could soon bleed over into biosimilar formulary placement.
